fbpx
Medical Innovation Exchange

Bristol Myers Squibb, with new positive lupus data in hand, readies TYK2 inhibitor for final test

https://www.fiercebiotech.com/biotech/bms-sets-sights-phase-3-lupus-trial-tyk2-inhibitor-year-after-positive-readout

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.